<DOC>
	<DOCNO>NCT00435370</DOCNO>
	<brief_summary>This study determine effectiveness tropisetron plus risperidone improve cognitive symptom Chinese people schizophrenia .</brief_summary>
	<brief_title>Effectiveness Tropisetron Plus Risperidone Improving Cognitive Perceptual Disturbances Schizophrenia</brief_title>
	<detailed_description>Schizophrenia chronic disable brain disorder . People schizophrenia may experience hallucination , delusion , disorder thinking , movement disorder , social withdrawal , cognitive deficit . In consider high rate cigarette smoke among people schizophrenia , also likely smoke . People schizophrenia smoke tend experience improve cognition , tobacco withdrawal associate deterioration cognition . This suggest nicotine may improve cognitive deficit medication side effect people schizophrenia . Auditory sensory gating , neural mechanism think reflect sensory information processing affect cognition , diminished people schizophrenia . Auditory sensory gating associate 7 nicotinic acetylcholine receptor , brain receptor important cognition activate nicotine . Activation receptor use agonist medication , tropisetron , may produce positive effect nicotine cognition . This study determine effectiveness use tropisetron supplemental therapy atypical neuroleptic risperidone people schizophrenia . Participants 12-week double blind study randomly assign receive either tropisetron placebo . All participant also follow 6-mg risperidone regimen . Study visit occur every 2 week throughout study final outcome assessment include cognitive functioning treatment safety effectiveness .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Tropisetron</mesh_term>
	<criteria>Currently reside Beijing , China Diagnosis schizophrenia schizophreniform disorder Duration symptom longer 60 month No history treatment antipsychotic medication , previously treat , total lifetime usage le 14 day Current psychotic symptom moderate severity great measure one five psychotic item Brief Psychiatric Rating Scale ( BPRS ) Diagnostic Statistical Manual Mental Disorders ( DSM ) IV Axis I diagnosis schizophrenia schizophreniform psychosis Documented disease central nervous system might interfere trial assessment ( e.g. , stroke , tumor , Parkinson 's disease , Huntington 's disease , seizure disorder , history brain trauma result significant impairment , chronic infection ) Acute , unstable , and/or significant untreated medical illness ( e.g. , infection , unstable diabetes , uncontrolled hypertension ) A clinically significant echocardiogram ( ECG ) abnormality opinion investigator Pregnant breastfeeding Use prohibit concomitant therapy History severe allergy hypersensitivity Dependence alcohol illegal drug Use follow medication trial : antipsychotic medication risperidone ; psychostimulants ; antidepressant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>